Sandra L. Fenwick's most recent trade in Teladoc Health Inc was a trade of 28,986 Restricted Stock Units done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 28,986 | 28,986 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 17,467 | 17,467 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 436 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 436 | 12,070 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,834 | 9,834 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 436 | 11,634 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 436 | 436 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 6,726 | 6,726 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 436 | 11,198 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 436 | 872 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 14 Oct 2021 | 3,587 | 10,762 (0%) | 0% | 140 | 502,180 | Common Stock |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Sale of securities on an exchange or to another person at price $ 164.63 per share. | 06 Jul 2021 | 7,173 | 14,349 (0%) | 0% | 164.6 | 1,180,891 | Common Stock |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 7,176 | 21,522 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 6,461 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 715 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 1,638 | 1,638 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 7,173 | 14,346 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 6,460 | 6,461 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 713 | 715 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 7,173 | 35,535 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 6,460 | 12,921 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 713 | 1,428 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Sandra L. Fenwick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 1,308 | 1,308 | - | - | Restricted Stock Units |